This application is a competing continuation of a grant to investigate the basic science aspects of schizophrenia as it relates to limbic system function. Evidence implicates several structures, including the prefrontal cortex, hippocampus, and the nucleus accumbens, in schizophrenia pathophysiology. In addition, manipulation of the dopamine system has been shown to regulate the interactions of these systems, and to be disrupted in schizophrenia. This study uses in vivo electrophysiological, neurochemical, and behavioral techniques to examine the interactions of these systems as they relate to schizophrenia. A large body of evidence suggests that the hippocampus is hyperactive in schizophrenia, which is consistent with findings from our developmental disruption model of schizophrenia using prenatal administration of the mitotoxin methylazoxymethanol acetate. However, how hyperactivity translates into imbalances with respect to dopamine-limbic system balance are unknown. In this application, we will test the hypothesis that hyperactivity within the ventral subiculum drives much of the pathophysiology of limbic system function characteristic of schizophrenia. This will be done along 4 specific aims: 1) examine the impact of sustained ventral subicular activity on the activity and interaction of neurons in the nucleus accumbens and medial prefrontal cortex., 2) examine the role of the medial prefrontal cortex in regulating ventral subiculum-nucleus accumbens interactions, 3) examine how ventral subicular activation modulates dopamine neuron firing and 4) examine the state of these systems interactions in the developmental model, with emphasis on how inactivation of the ventral subiculum can restore these parameters to normal. In this way, we hope to provide important insights into the pathophysiology of schizophrenia and propose a novel therapeutic target for its alleviation. Relevance to public health issues: Schizophrenia is a devastating disorder that incapacitates 1% of the world population, costing hundreds of billions of dollars in health care and lost income annually. This study examines the basic biology of systems with known involvement in schizophrenia, based on the developmental nature of the disorder. The results will provide important new information regarding how these systems interact in normal and pathological states, and how function may be restored to a disordered dopamine system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH057440-15
Application #
8112562
Study Section
Special Emphasis Panel (ZRG1-BDCN-A (90))
Program Officer
Meinecke, Douglas L
Project Start
1997-08-15
Project End
2012-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
15
Fiscal Year
2011
Total Cost
$328,299
Indirect Cost
Name
University of Pittsburgh
Department
Neurosciences
Type
Schools of Arts and Sciences
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Zhu, Xiyu; Gomes, Felipe V; Grace, Anthony A (2017) The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex: An Editorial Highlight for 'Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM J Neurochem 143:264-267
Grace, Anthony A (2017) Dopamine System Dysregulation and the Pathophysiology of Schizophrenia: Insights From the Methylazoxymethanol Acetate Model. Biol Psychiatry 81:5-8
Gomes, Felipe V; Rincón-Cortés, Millie; Grace, Anthony A (2016) Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model. Neurosci Biobehav Rev 70:260-270
Zimmerman, Eric C; Grace, Anthony A (2016) The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity. J Neurosci 36:8977-84
Du, Yijuan; Grace, Anthony A (2016) Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam. Int J Neuropsychopharmacol 19:
Du, Yijuan; Grace, Anthony A (2016) Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration. Neuropsychopharmacology 41:2455-62
Harun, R; Hare, K M; Brough, M E et al. (2015) Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent regionally selective, bimodal effects on striatal dopamine kinetics in vivo. J Neurochem :
Modinos, Gemma; Allen, Paul; Grace, Anthony A et al. (2015) Translating the MAM model of psychosis to humans. Trends Neurosci 38:129-38
Richetto, Juliet; Labouesse, Marie A; Poe, Michael M et al. (2015) Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH? in an immune-mediated neurodevelopmental disruption model. Int J Neuropsychopharmacol 18:
Deserno, Lorenz; Huys, Quentin J M; Boehme, Rebecca et al. (2015) Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making. Proc Natl Acad Sci U S A 112:1595-600

Showing the most recent 10 out of 80 publications